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Adipose-resident T cells (ARTs) regulate metabolic
and inflammatory responses in obesity, but ART
activation signals are poorly understood. Here, we
describe class II major histocompatibility complex
(MHCII) as an important component of high-fat-
diet (HFD)-induced obesity. Microarray analysis of
primary adipocytes revealed that multiple genes
involved in MHCII antigen processing and presenta-
tion increased in obese women. In mice, adipocyte
MHCII increased within 2 weeks on HFD, paralleling
increases in proinflammatory ART markers and
decreases in anti-inflammatory ART markers, and
preceding adipose tissue macrophage (ATM) accu-
mulation and proinflammatory M1 polarization.
Mouse 3T3-L1 and primary adipocytes activated
T cells in an antigen-specific, contact-dependent
manner, indicating that adipocyte MHCII is func-
tional. HFD-fed MHCII/ mice developed less
adipose inflammation and insulin resistance than
did wild-type mice, despite developing similar adi-
posity. These investigations uncover a mechanism
whereby a HFD-induced adipocyte/ART dialog in-
volving MHCII instigates adipose inflammation and,
together with ATM MHCII, escalates its progression.
INTRODUCTION
While changes in adipose tissue T cells and macrophages
induced by high-fat diet (HFD) are recognized as important
determinants of adipose metabolism, proinflammatory cytokine
secretion, and whole-body insulin sensitivity (Finlay and Cantrell,
2011; Olefsky and Glass, 2010; Weisberg et al., 2003; Xu et al.,
2003), the nature and source of early signals that trigger the
proinflammatory phenotype in adipose tissue remain unclear.
Adipose inflammation results from the integration of multiple
interactions among adipocytes and immune cells. In obesity,
adipocytes secrete less anti-inflammatory adiponectin andCeincrease expression of proinflammatory factors (TNF-a, IL-6,
RBP4, and ANGPTL2), macrophage chemoattractants (MCP-1
and NAMPT), and leptin to induce proinflammatory immune
cell responses (Ferna´ndez-Riejos et al., 2010; Lord et al., 1998;
Ouchi et al., 2011). ATMs reciprocally secrete cytokines (TNF-a
and IL-1b) that can alter adipocyte lipid storage, lipolysis,
insulin responses, glucose metabolism, and adipokine produc-
tion, leading to ectopic fat deposition and systemic inflammation
that results in whole-body insulin resistance (Guilherme et al.,
2008). Attenuating these inflammatory responses by macro-
phage-specific IKKb and JNK knockout or whole-body TNFa
neutralization attenuates insulin resistance, hepatic steatosis,
and atherosclerosis, while mutations that increase inflammatory
responses or polarization to a proinflammatory M1 phenotype
have the opposite effect (Arkan et al., 2005; Chawla, 2010; Han
et al., 2013; Hevener et al., 2007; Hotamisligil et al., 1993; Lu-
meng et al., 2007; Olefsky and Glass, 2010). These observations
highlight the importance of the adipocyte/macrophage dialog.
Adipocyte death has been proposed to promote recruitment of
proinflammatory macrophages into adipose tissue, since M1-
like ATMs form characteristic ‘‘crown-like structures’’ around
dying hypertrophic adipocytes that accumulate with obesity
(Sun et al., 2011). Recent results, however, indicate that
ATMs surrounding adipocytes are primarily M2 macrophages
(Fischer-Posovszky et al., 2011) and can accumulate in the
absence of adipocyte death (Feng et al., 2011), suggesting that
cells other than apoptotic adipocytes regulate ATM accumula-
tion and M1 polarization in obesity.
Adipose-resident T cells (ARTs) are increasingly recognized
to modulate adipose tissue inflammation and systemic insulin
action, interacting with both adipocytes and macrophages
(Kintscher et al., 2008; Nishimura et al., 2009; Wu et al., 2007).
HFD challenge increases adipose CD8+ T cells (Finlay and Can-
trell, 2011; Nishimura et al., 2009) and CD4+ TH1 cells, leading
to increases in ART IFNg production, which can promote adipo-
cyte lipolysis and ATMM1polarization (Finlay andCantrell, 2011;
Strissel et al., 2010; Yang et al., 2010), and decreases CD4+ TH2
and TREG cells, which neutralize inflammation and produce IL-4
to promote M2 polarization (Biswas and Mantovani, 2010; Tie-
messen et al., 2007). Increasing adipose TREG numbers or levels
of IL-10, an anti-inflammatory cytokine, can decrease M1 ATMs,
systemic insulin resistance, and liver steatosis (Feuerer et al.,ll Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc. 411
Table 1. Human Microarray Data
Gene ID FC p Value Description
MHC Gene Pathway Transcription
CIITA 1.03 0.872 class II transactivator
RFX5 0.97 0.921 regulatory factor X (RFX) 5
RFXANK 0.57 0.069 RFX-associated ankyrin-containing
protein
RFXAP 0.79 0.506 RFX-associated protein
NFYA 1.22 0.246 nuclear transcription factor Y alpha
NFYB 1.04 0.914 nuclear transcription factor Y beta
NFYC 0.75 0.354 nuclear transcription factor Y gamma
CREB1 0.53 0.008 cAMP responsive element binding
protein 1
MHCII-Mediated Antigen Presentation
CD74 2.69 0.002 MHCII invariant chain
HLA-DMA 1.16 0.44 HLA-DMA
HLA-DMB 2.65 0.001 HLA-DMB
HLA-DOA 1.38 0.239 HLA-DOA
HLA-DOB 1.08 0.781 HLA-DOB
HLA-DPA1 2.14 0.016 HLA-DPA1
HLA-DPB1 1.93 0.035 HLA-DPB1
HLA-DQA1 1.92 0.012 HLA-DQA1
HLA-DQA2 2.03 0.052 HLA-DQA2
HLA-DQB1 1.08 0.575 HLA-DQB1
HLA-DRA 2.56 0.003 HLA-DRA
HLA-DRB1 2.29 0.006 HLA-DRB1
HLA-DRB3 2.58 0.007 HLA-DRB3
HLA-DRB4 2.97 0.001 HLA-DRB4
HLA-DRB5 1.83 0.047 HLA-DRB5
MHCII Antigen Processing
CTSB 1.81 0.02 cathepsin B
CTSL1 0.58 0.126 cathepsin L1
CTSS 2.06 0.011 cathepsin S
IFI30 2.13 0.027 interferon, gamma-inducible
protein 30
LGMN 1.73 0.085 legumain
Costimulatory Molecules
CD80 0.84 0.626 CD80 molecule
CD86 2.40 0.001 CD86 molecule
MHCI-Mediated Antigen Presentation
B2M 1.22 0.42 B2M:beta-2-microglobulin
HLA-A 1.07 0.766 HLA-A
HLA-B 0.85 0.49 HLA-B
HLA-C 1.53 0.158 HLA-C
HLA-E 1.19 0.51 HLA-E
HLA-F 1.44 0.092 HLA-F
HLA-G 0.97 0.909 HLA-G
Microarray analyses revealed that multiple MHCII genes were upregu-
lated in adipocytes from seven obese versus seven lean postmenopausal
women shown as relative fold change. Bold text denotes genes with
greater than 1.5-fold change and p < 0.05 by t test.
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to secrete cytokines and proliferate requires recognition of
a specific peptide antigen:MHCII complex on an antigen-pre-
senting cell (APC) in conjunction with costimulatory signals.
Macrophages and dendritic cells are professional APCs; thus,
ATMs could be responsible for activation of CD4+ T cells in in-
flamed adipose tissue. However, several studies have detected
changes in ART composition that precede changes in ATM
number and polarization, so the mechanism regulating ART
responses to HFD remains a compelling question (Lumeng
et al., 2009).
To define adipocyte changes that are associated with obesity
and could trigger changes in immune cell phenotypes, wemicro-
array profiled purified human adipocytes isolated from surgical
adipose biopsies of obese and lean women. Surprisingly, ex-
pression of class II transactivator (CIITA), the master tran-
scriptional regulator of the MHCII pathway, and multiple MHCII
family genes including costimulators were markedly increased
in adipocytes of obese subjects. Similar increases were ob-
served in mouse adipocytes isolated after only 2 weeks of HFD
challenge. These changes paralleled ART activation but pre-
ceded changes in macrophage abundance or polarization.
Moreover, adipocytes were found to potently activate T cells in
an antigen- and contact-dependent manner that was enhanced
in obesity, and MHCII deficiency attenuated inflammatory and
metabolic responses to HFD. We propose that activation of adi-
pocyte adaptive immunity regulates changes in ART subtypes
early in HFD challenge, triggering a proinflammatory dialog
between adipocytes and ARTs that then promotes ATM recruit-
ment and M1 polarization. Ultimately both adipocytes and
ATMs contribute to T cell activation later during HFD. These
results underscore a role for the adipocyte in instigating adipose
inflammation, provide a time course of adipose immune cell
changes in response to HFD challenge, and emphasize an
essential role of adaptive immunity in obesity that has thera-
peutic implications.
RESULTS
Obesity Is Associated with Increased MHCII in Primary
Human and Mouse Adipocytes, but Not in ATMs
To identify adipocyte genes impacted by obesity, adipocytes
were isolated from surgical adipose biopsies of 44 women
and then CD45-immunoprecipitated to remove residual leuko-
cyte contamination. Microarray analysis was performed to iden-
tify genes differentially expressed (>1.5-fold absolute change,
p < 0.05) in subcutaneous (SQ) adipocyte RNA isolated from
lean and obese postmenopausal women (see Table S1 online).
Gene set enrichment analysis performed on this data found
that nine of the top ten upregulated pathways (Table S2) demon-
strated substantial overlap due to shared expression of multiple
MHCII genes, and that 11 of 15 genes involved in MHCII
antigen presentation, 3 of 5 involved in MHCII antigen pro-
cessing, and the costimulatory molecule CD86 increased with
obesity (Table 1). In contrast, there were no increases in MHCI-
related genes in the microarray. Confirming these results, RT-
PCR analysis of CIITA, the MHCII invariant chain peptide
CD74, and the MHCII proteins HLA-DMB and HLA-DBP in SQ
and visceral (V) adipocytes of lean and obese postmenopausal412 Cell Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc.
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Figure 1. Adipocyte MHCII mRNA and Protein Expression Is Markedly Increased with Obesity
RT-PCR analysis of MHCII family genes in (A) subcutaneous (SQA) and visceral (VA) adipocytes and (B) SQ ATMs of lean and obese women (n = 5–19/group). (C)
Representative flow cytometry images of human SVF and adipocyte samples hybridized with fluorescent antibodies specific for human MHCII (pan HLA-DR),
CD36, and CD45. Arrows indicate nonspecific signal from residual magnetic beads not removed during the CD45-depletion procedure. RT-PCR of MHCII family
genes in (D) SQ and V adipocytes and (E) V adipocytes and V ATMs (n = 4/group) of male C57BL/6 mice fed 3 months chow (lean) or HFD (obese). Western blot
analysis of MHC family proteins in (F) V adipocytes from lean and obese male C57BL/6 mice and (G) V adipocytes and V ATMs from obese male C57BL/6 mice
(n = 3 samples [two to three mice/sample]/group; p < 0.05 versus matching lean [*] or SQA [y] sample by Mann-Whitney [A–E] or Welch’s t test [F and G]). Each
mouse sample represents pooled material obtained from four (adipocytes) or eight (ATMs) mice. Data represent means ± SEM.
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However, no similar changes were detected in ATMs of lean
versus obese subjects (Figure 1B). Expression of the major
costimulatory genes CD80 and CD86 was also increased in
adipocytes of obese versus lean women (Figure S1A). Low-pres-
sure, image-capture flow cytometry analyses of humanSQ and V
adipocyte and SVF samples were performed to confirm adipo-
cyte MHCII expression and purity. Cells in adipocyte fractions
were morphologically distinct and uniformly expressed the fatty
acid transporter CD36 (Figure 1C), used as amarker of adipocyte
integrity, but not the panleukocyte marker CD45 (<0.1% CD45+
cells detected, Figure S2). MHCII+ SVF cells were smaller,
translucent, and highly expressed both MHCII and CD45, with
a subpopulation also expressing CD36.
Similar MHCII expression was observed in obese mouse
models. Both SQ and V adipocytes of male C57BL/6 mice with
diet-induced obesity demonstrated increased MHCII expres-
sion, more so in V than in SQ adipocytes (Figure 1D). CD45-
depleted V adipocytes expressed more MHCII mRNA (H2-Eb1,
6-fold) and protein (4-fold) than lean mice (Figures 1E and 1F)
with increased costimulatory molecule expression (Figure S1B).CeIn contrast, there was no change in MHCI mRNA (data not
shown) or protein (Figure 1F). ATM Ciita mRNA expression
modestly increased with obesity in these mice, but ATM H2-
Eb1 and CD74 mRNA expression did not significantly increase.
Adipocyte MHCII mRNA (H2-Eb1) expression in HFD-fed mice
thus approached that found in ATM of chow- and HFD-fed
mice, resulting in a nonsignificant difference in MHCII protein
expression in adipocytes versus ATMs of HFD-fed mice (Figures
1E and 1G). Similar results were found in middle-aged male
Ldlr/ mice fed western diet; these mice develop obesity-
related complications closely resembling human nonalchoholic
steatohepatitis and atherosclerosis (Collins et al., 2009; Gupte
et al., 2010). Here, again, there was increased MHCII (H2-Eb1
and H2-DMa) expression in adipocytes, but not ATMs, with
HFD (Figure S1C).
Leptin Stimulates IFNg Secretion from T Cells to Induce
Adipocyte MHCII Expression
Adipose tissue produces multiple proinflammatory factors that
are upregulated in obesity, including IFNg, a known regulator
of CIITA expression and an important contributor to adiposell Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc. 413
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Figure 2. Leptin-Induced IFNg from T Cells Stimulates Adipocyte MHCII Expression
(A–D) MHCII family gene induction in (A and B) differentiated primary human adipocytes and (C and D) mouse 3T3-L1 preadipocytes and adipocytes cultured for
24 hr with PBS (NC, vehicle), IFNg, TNFa, IL-1b, or IL-6.
(E) IFNg dose response of CIITA expression in 3T3-L1 adipocytes.
(F) IFNg secretion by C57BL/6 splenic T cells incubated 24 hr with 1 mg/ml leptin.
(G) 3T3-L1 adipocyte MHCII induction by supernatant of splenic T cells incubated with PBS (NC), leptin + control IgG (IgG), or leptin + IFNg-neutralizing
antibody (aIFN).
(H) Correlation of z skew normalized humanSQ adipocyte CIITAmRNA (zSA.CIITA) with plasma leptin (zLeptin) and SQ adipocyte leptinmRNA (zSA.Lep). (n = 35–
40; dashed line indicates the 95% confidence interval of the regression line).
(I) MHCII expression in peritoneal macrophages (PM) and 3T3-L1 adipocytes treated 24 hr with PBS (NC) or IFNg ± 4 hr pretreatment with IL-10.
(J) IL-10Ra/b expression in PMs, 3T3-L1 adipocytes, and mouse primary ATM and adipocytes. Data represent means ± SEM (A–G, I–J, n = 2–4/group; p < 0.05
versus matching NC [*], or preadipocyte [y] or PM [z] treatment group by t test or one-way ANOVA).
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Adaptive Immunity Impacts Adipose Inflammationinflammation and metabolic responses to HFD (Rocha et al.,
2008). To investigate transcriptional regulation of adipocyte
CIITA, differentiated human primary adipocytes were incubated
with cytokines known to increase with obesity. Among these
cytokines, only IFNg induced CIITA and MHCII expression
(Figures 2A and 2B). Similar results were found with differenti-
ated mouse 3T3-L1 adipocytes (Figures 2C and 2D), where
MHCII induction was markedly lower (10%) in 3T3-L1 preadi-
pocytes, indicating a preferential response in differentiated
adipocytes. IFNg, but not other cytokines (data not shown),
also stimulated MHCII (H2-Eb1) in differentiated primary mouse
adipocytes, such that adipocyte Ciita expression was increased414 Cell Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc.2-fold by 30 pg/ml IFNg and progressively increased thereafter
(Figure 2E).
CD4+ TH1 T cells secrete IFNg upon leptin stimulation (Lord
et al., 1998). Accordingly, we found that leptin markedly induced
IFNg secretion from splenic T cells and that supernatant from
these cells induced Ciita expression in 3T3-L1 adipocytes in a
manner that was completely attenuated by prior addition of
IFNg-neutralizing antibody (Figures 2F and 2G). These results
suggest that adipocyte-derived leptin can stimulate CD4+ TH1
IFNg secretion to induce adipocyte MHCII expression. More-
over, human SQ adipocyte CIITA mRNA expression correlated
with both SQ adipocyte leptin expression and plasma leptin
Cell Metabolism
Adaptive Immunity Impacts Adipose Inflammationlevels (Figure 2H), suggesting that this mechanism may be oper-
ative in human adipose.
IL-10 Modifies Macrophage, but Not Adipocyte,
Responses to IFNg
IL-10 is an anti-inflammatory cytokine that can attenuate macro-
phageMHCII expression (deWaalMalefyt et al., 1991). However,
unlike macrophages, coinduction with IL-10 did not attenuate
IFNg-induced MHCII expression in adipocytes (Figure 2I). This
adipocyte IL-10 resistance was likely due to low IL-10Ra and
IL-10Rb gene expression: both 3T3-L1 and primary mouse
adipocytes had substantially lower expression of these recep-
tors than mouse peritoneal macrophages or ATMs (Figure 2J).
Thus, differential MHCII responses in adipocytes and ATMs
during obesity may result from differential responses to
increased adipose tissue IL-10 expression, which occurs in
obesity (see below).
Adipocyte MHCII Expression Is an Early Response to
Diet-Induced Obesity
To determine the time course of adipose gene expression and
mouse phenotypic changes, RNA was isolated from adipose
tissue, adipocytes, ARTs, and ATMs of C57BL/6 mice fed
chow or HFD for 1–12 weeks and RT-PCR analyzed for altered
expression of cell lineage and phenotype marker genes. HFD-
fed mice gained weight at twice the rate of chow-fed mice,
predominantly as adipose tissue, developing significantly in-
creased fasting glucose and insulin within 2 weeks of HFD
(Figures S3A and S3B). Adipose tissue expression of T cell
(Cd3d) and macrophage (Emr1) marker genes did not increase
until after 4 weeks HFD (Figure 3A). However, expression of
several adipocyte genes exhibited progressive increases: leptin
increased within 1 week of HFD followed by MHCII family
genes at 2 weeks HFD, and both gene sets increased markedly
by 12 weeks (Figure 3B). Adipocyte IL-10 mRNA changes paral-
leled those of leptin, increasing by 4-fold during the first 4 weeks
of HFD and nearly 150-fold by 12weeks. Adipocyte macrophage
chemoattractant protein-1 (MCP-1; Ccl2) gene expression did
not increase until 4 weeks of HFD, consistent with delayed
macrophage accumulation (adipose expression of Emr1). Adipo-
cyte mRNA expression of TNF-a, implicated to mediate insulin
resistance in obesity (Hotamisligil, 1999), and NLRP3, which
forms an inflammasome to activate caspase-1 for the cleavage
of pro-IL-1b to mature IL-1b (Wen et al., 2012), increased only
at 12 weeks (Figure 3B). ARTs also demonstrated early changes:
expression of the proinflammatory TH1 marker genes Tbx21 and
Ifng increased within 2 weeks of HFD, corresponding to the
development of glucose intolerance and insulin resistance
(Figures S3C–S3E), followed by reduced expression of anti-
inflammatory TH2 (Gata3) and Treg (Foxp3) marker genes (Fig-
ure 3C). Changes in ATM polarization with HFD occurred after
T cell changes (Figure 3D), as indicated by increased expression
of the M1 polarization marker Itgax (CD11c) and decreased
expression of the anti-inflammatory M2 markers Arg1 and
Mrc1 at 12 weeks HFD. ATM cytokine expression paralleled
changes in polarization markers, with IL-1b and TNF-a gene
expression increasing only at 12 weeks of HFD, although, unlike
adipocytes, ATM Nlrp3 expression did not increase with HFD
(Figure 3D). Insulin tolerance tests and HOMA-IR measurementsCeperformed at 4 weeks of HFD, prior to adipose macrophage infil-
tration or ATM inflammatory changes, indicated the presence of
insulin resistance, suggesting that early systemic metabolic
changes occur prior to detectable ATM changes (Figures S3E
and S3F).
Since findings outlined above pointed to an early role for leptin
in ART activation, adipose phenotypes of C57BL/6mice fed HFD
for 3 months and C57BL/6-background leptin-deficient (ob/ob)
mice of similar weight (C57 40.3 g versus ob/ob 44.6 g, p <
0.05) were compared to evaluate the impact of leptin on adipose
inflammation. Despite greater adiposity (ob/ob 52.5% fat versus
C57 32.0% fat), adipose tissue of ob/ob mice expressed less
Cd3d and Emr1 than did HFD-fed C57BL/6 mice, indicating
reduced immune cell content (Figure 3E). Adipocytes of ob/ob
mice also expressed less MHCII than did HFD-fed C57BL/6
mice, while their ARTs expressed less Tbx21 and Ifng, and their
ATMs revealed less M1 polarization (Figures 3F–3H), indicating
an attenuation of the proinflammatory impact of obesity in
leptin-deficient ob/ob mice. However, anti-inflammatory TH2
(Gata3), Treg (Foxp3), and M2 macrophage (Arg1 and Mrc1)
markers similarly decreased in both groups (Figures 3G and
3H), suggesting different mechanisms may impact these pro-
and anti-inflammatory changes. These data suggest that loss
of leptin-stimulated IFNg expression attenuates adipose adap-
tive immune mechanisms and M1 polarization.
In humanSVF, obese versus lean subjects had greater expres-
sion of IFNg (Figure 3I) and the TH1 marker, TBX21, (Figure 3J),
but no differences in TH2 (GATA3) or Treg (FOXP3) markers.
Adipocyte-Mediated CD4 T Cell Activation Is MHCII and
Antigen Dependent
CD4+ T cells secrete IL-2 to induce antigen-specific T cell clonal
expansion upon interaction with MHCII-presented antigens. To
test the ability of primary mouse adipocytes to activate CD4+
T cells, CD45-depleted adipocytes isolated from lean and obese
Ldlr/mice were cultured with or without splenic T cells specific
for MHCII-presented ovalbumin, in the presence or absence of
ovalbumin. Isolated adipocytes and T cells were cocultured or
cultured in wells separated by a cytokine-permeable membrane
to determine the contact dependence of adipocyte-mediated
T cell activation. After 48 hr, cell culture supernatants were
analyzed for cytokines involved in T cell activation and proinflam-
matory TH1 cell polarization. IL-2 was not significantly secreted
by adipocytes or T cells cultured separately; however, adipocyte
and T cell cocultures exhibited a dramatic increase in IL-2
production in an antigen-dependent manner (Figure 4A). The
3-fold difference between IL-2 secretion in obese versus lean
mouse adipocyte cocultures corresponded with adipocyte
MHCII protein differences observed in these mice (Figure 1D).
IFNg, which is predominantly secreted by TH1 cells after
MHCII-restricted activation, was also increased (5-fold) in
obese versus lean cocultures (Figure 4B) but was almost unde-
tectable in separate adipocyte or T cell cultures (data not shown).
IL-4, primarily secreted by TH2 cells, was essentially undetect-
able in this assay (data not shown). Adipocytes of HFD-fed
mice were also found to induce more antigen-dependent T cell
DNA replication than those of chow-fed mice (Figure 4C).
Studies were also performed with 3T3-L1 adipocytes stably
transduced with CIITA-shRNA or negative control (NC)-shRNAll Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc. 415
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Figure 3. Adipocyte MHCII and ARTs Changes Occur Early after HFD, while ATM Changes Occur Later
RT-PCR analysis of (A) adipose tissue, (B) CD45-depleted adipocytes, (C) ARTs, and (D) ATMs of male C57BL/6 mice fed HFD for 1, 2, 3, 4, or 12 weeks; and (E)
adipose tissue, (F) CD45-depleted adipocytes, (G) ARTs, and (H) ATMs of similar weight male ob/ob mice and 12 week HFD-fed C57BL/6 mice. (n = 4–8/group,
p < 0.05 and >1.5-fold absolute change versus matching chow control [*] or ob/ob mouse [y] expression by Mann-Whitney tests.) ART and ATM samples
represent pooled material obtained from four (adipocytes) or eight (ARTs and ATMs) mice. All data are normalized against the expression of matching chow-fed
lean control mice (red line). RT-PCR analysis of human SVF expression of (I) IFNG and (J) CD3D-normalized expression of the ART lineage markers TBX21,
FOXP3, and GATA3 (n = 6–15, *p < 0.05 by Welch’s t test). Data represent means ± SEM.
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Adaptive Immunity Impacts Adipose Inflammationlentiviral constructs to verify that adipocyte MHCII expres-
sion was required for T cell activation. MHCII expression was
induced by IFNg treatment, and both IFNg-treated and un-
treated cells were cocultured with splenic T cells of haplotype-
matched DHA1 mice immunized with chicken ovalbumin. Cell
culture supernatants were collected after 48 hr of coculture
and analyzed for IL-2 and IFNg concentrations. Strong cyto-
kine responses were induced only in IFNg-treated adipocytes
incubated with ovalbumin (Figures 4D and 4E), while cyto-
kine induction was attenuated 50% in adipocytes expressing
Ciita-shRNA, corresponding to the degree of CIITA knockdown416 Cell Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc.(Figure 4F). Neither ovalbumin treatment nor IFNg treatment
alone was sufficient to stimulate IL-2 or IFNg secretion. Finally,
unstimulated primary mouse preadipocytes and adipocytes
induced less T cell activation (30%) than BMDMs, and activity
markedly increased in all cell types after IFNg exposure (Figures
4G and 4H). Taken together, these data indicate that (1) adipo-
cytes can function as APCs to induce CD4+ T cell activation
and polarization, (2) this activity increases with obesity in corre-
spondence with increasing CIITA and MHCII mRNA and protein
expression, and (3) adipocyte activation of T cells approaches
that of BMDMs.
A B C
D E F
G H
Figure 4. Adipocytes Can Present MHCII Antigens to Activate CD4+ T Cells
Chow- and HFD-fed C57BL/6J mouse adipocytes (Adip) and ovalbumin (OVA)-specific CD4+ T cells (T) were cultured alone or cocultured in direct contact
(Adip+T) or in separate chambers of a transwell plate (Adip//T). Cultures were incubated 48 hr ± OVA, after which supernatants were analyzed for (A) IL-2 and (B)
IFNg or (C) incubated with 3H-thymidine for 16 hr to assess antigen-stimulated T cell replication. (n = 2–3/group, 3 mice/adipocyte sample, p < 0.05 versus
T cells ± OVA and adipocytes without OVA [*] or matching chow [y] control by t test.) 3T3-L1 adipocyte cultures expressing negative control (shNC) or Ciita
(shCiita) shRNAs were treated 24 hr ± INFg, cocultured for 48 hr with CD4+ T cells of OVA-immunized mice ± OVA, and then analyzed for (D) IL-2 and (E) IFNg
secretion, and analyzed for (F) CIITA protein expression. (n = 2–3/group, p < 0.05 versus matching NC [*] or matching shNC [y] expression by t test.) Red line
indicates the concentration of the lowest ELISA standard. C5BL/6J mouse preadipocytes (preAd), differentiated adipocytes (Ad), and BMDMs treated with or
without IFNg, incubated ± OVA for and OVA-specific T cells for 48 hr and assessed for (G) IL-2 and (H) IFNg production. (n = 4/group, p < 0.05 versus matching
T+OVA [y] by t test or versus preAd and Ad [*] or all others [x] by ANOVA.) Data represent means ± SEM.
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and Are More Insulin Sensitive when Fed HFD
To determine the importance of MHCII-mediated mechanisms
in metabolic responses to caloric excess, MHCII-deficient
(H2A/) and WT mice were fed chow or HFD for 3 months
and analyzed for whole adipose, adipocyte, ART, ATM, and
metabolic differences. Both H2A/ and WT mice developed
similar adiposity on chow and HFD, although H2A/ mice had
slightly lower starting body weights, gained slightly less weight
than WT mice when fed either chow or HFD, and had reduced
plasma leptin (Figures S4A–S4D). Although HFD-fed H2A/
mice had similar fasting plasma glucose and adiposity as WT
mice, H2A/ mice had lower fasting insulin levels, greater
insulin sensitivity, and, consistent with thesemetabolic changes,
less liver steatosis than WT mice (Figures 5A–5C). RT-PCR anal-Ceysis also found reduced expression of the macrophage marker
Emr1 in adipose tissue of HFD-fed H2A/ mice, in agreement
with reduced macrophage accumulation by immunohistology,
and less mRNA expression of the proinflammatory cytokines
MCP-1 and TNF-a, with no difference in leptin expression (Fig-
ures 5D and 5E). RT-PCR analysis found that adipocytes isolated
from HFD-fed H2A/ mice did not markedly differ at 2 weeks
HFD but by 12 weeks expressed more adiponectin and less
Tnf and Nlrp3 than those of WT mice, indicating reduced adipo-
cyte inflammation (Figure 5F). Flow cytometry of SVF from
H2A/ mice revealed reduced CD4+ T cells and increased
CD8+ T cells (Figure 5G), as previously reported for H2A/
mice (Madsen et al., 1999). HFD challenge decreased CD4+
ARTs and increased CD8+ ARTs in SVF of WT mice, and further
increased CD8+ ARTs in SVF of H2A/ mice, with no effect onll Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc. 417
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Figure 5. HFD-Fed MHCII-Deficient Mice Have Less Adipose Inflammation and Insulin Resistance
(A) Fasting plasma glucose and insulin levels, (B) intraperitoneal insulin tolerance test data of H2A/ andWTmice fed 3 months of chow or HFD (n = 6–7/group),
and liver steatosis analyzed by (C) NMR and hematoxylin and eosin staining. Adipose inflammation was assessed by (D) F4/80 immunhistochemistry and (E) RT-
PCR, while relative (F) adipocyte changes were analyzed by RT-PCR. SVF (G) ART and (H) ATM abundance was assessed by flow cytometry, and (I) ART and (J)
ATM fractions were analyzed by RT-PCR (n = 4–6/group). ART and ATM samples represent pooled material obtained from four (adipocytes) or eight (ARTs and
ATMs) mice (p < 0.05 versus genotype-matched [*] or diet-matched [y] expression by t test). Data represent means ± SEM.
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fed mouse groups but increased more in SVF of HFD-fed WT
versus H2A/ mice (Figure 5H). Similarly, ARTs of H2A/
mice expressed less Cd4 and more Cd8a at 2 and 12 weeks
HFD than WT mice; Ifng expression was similar at 2 weeks
but half that of WT mice at 12 weeks (Figure 5I). ATMs did not
differ at 2 weeks, but revealed an attenuation of the M1 polariza-
tion profile that occurred in WT mice, with increased expression
of the M2 marker Arg1 and reduced expression of the M1
markers Itgax, Nos2, and Tnf at 12 weeks (Figure 5J). Taken
together these results demonstrate that MHCII deficiency atten-
uates adipose inflammatory and metabolic responses to HFD,
indicating an important role for MHCII and activation of CD4+
T cells in the proinflammatory response of adipose tissue toHFD.
Because of the improved metabolic responses to HFD in
H2A/ mice, we investigated insulin responses in primary adi-
pocytes isolated from H2A/ versus WT mice. Adipocytes
of HFD-fed H2A/ mice revealed greater insulin-stimulated
glucose uptake than those of WT mice. Although there was little
difference in insulin-stimulated pAKT/AKT protein ratios, H2A/
adipocytes demonstrated less repression of the adipogenic and418 Cell Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc.insulin-sensitizing transcription factors Pparg, Irs1, and Pik3r3,
whose protein binds IRS1 during insulin stimulation (Figures
S4E–S4G). In contrast, attenuation of IFNg-stimulated MHCII
expression by shRNA mediated Ciita knockdown and did not
alter insulin-mediated glucose uptake or isoproterenol-induced
lipolysis in 3T3-L1 adipocytes (Figures S4H and S4I). Thus,
MCHII deficiency does not appear to impact adipocyte metabo-
lism through intracellular-mediated effects, but likely exerts its
beneficial effects by decreasing local inflammation.
H2A/ mice were additionally studied at 4 weeks HFD, when
adipocytes and T cells instigate adipose inflammation in WT
mice. At this time there were no differences in body weight and
plasma lipids in HFD-fed WT and H2A/ mice (Figures S5A
and S5B); however, the H2A/mice were more insulin sensitive
than WT mice (Figure S5C). Thus, loss of adipocyte MHCII may
impact systemic insulin resistanceearly afterHFDadministration.
DISCUSSION
Cytokine production triggered by innate immune processes in
both ATMs and adipocytes drives adipose tissue inflammation
Figure 6. Model of Adipose Tissue Cell Interactions during HFD-
Induced Inflammation
Nutrient excess increases (1) adipocyte leptin (1 week), inducing (2) CD4+ ART
IFNg expression (2 weeks) to stimulate (3) adipocyte CIITA and MHCII
expression (2–3weeks). (4)MHCII antigen presentation by adipocytes, or other
APCs, stimulates CD4+ ART proliferation and differentiation. (5) Increased
adipocyte IL-10, starting at 1 week HFD, may attenuate proinflammatory ATM
polarization and APC function. By 12 weeks HFD challenge, ART activation/
proliferation stimulates (6) ATM accumulation and polarization to escalate
adipose inflammation.
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of ATMs (Anderson et al., 2010; Olefsky and Glass, 2010).
However, the contributions of adaptive immunity to the estab-
lishment of inflamed adipose tissue are much less clear. A
previous microarray study reported increased expression of
components of the MHCII pathway in obese versus lean adipose
tissue, but no investigations have precisely delineated the func-
tional importance of this pathway (Klimca´kova´ et al., 2011).
Observations that T cells accumulate in adipose tissue during
HFD to influence ATM phenotypes and insulin sensitivity and
that the adipose CD4+ T cell receptor repertoire is restricted,
suggestive of selection for specific antigen recognition (Feuerer
et al., 2009; Winer et al., 2009), emphasizes the potential impor-
tance of this pathway. We now report that both SQ and V adipo-
cytes of obese humans and mice, but not lean equivalents,
express all MHCII components required for antigen presentation
and that primary mouse adipocytes can induce antigen-specific
CD4+ T cell activation. Surprisingly, adipocytes isolated from
obese mice revealed MHCII mRNA levels approaching those of
ATMs after 12 weeks of HFD, while western blot analysis
detected similar adipocyte and ATM MHCII protein levels, con-
firming that adipocytes express substantial levels of MHCII
protein. Moreover, mature adipocytes could activate T cells
nearly as well as macrophages. Leptin, known to promote
T cell proliferation and cytokine secretion (Lord et al., 1998),
increased within 1 week of HFD challenge, and adipocyte MHCII
and costimulatorymolecule expression increasedwithin 2weeks
of HFD, corresponding to increases in adipose tissue proinflam-
matory TH1 cell differentiation and IFNg expression and pre-
ceding decreases in TH2 and TREG markers. ATM infiltration
and M2 to M1 polarization did not occur until well after these
ARTs changes, and ATM MHCII expression did not change
with HFD. Together these data suggest that induction of adipo-
cyte MHCII contributes to the early activation and polarization of
ARTs after HFD challenge. However, the lack of an adipocyte-
specific MHCII knockout mouse precludes a definitive conclu-
sion. Nevertheless, our investigation suggests that adaptive
immunity is necessary for adipose inflammation.
Leptin is an important contributor to the initiation of the
adipose inflammatory cascade. Leptin receptor expression is
prominent on human ARTs and increases with obesity (Duffaut
et al., 2009). Leptin signaling induces T cell IFNg secretion, stim-
ulating TH1 and repressing TH2 differentiation (Lord et al., 1998).
We found that supernatant of leptin-treated T cells enhanced
CIITA expression in 3T3-L1 adipocytes, but this effect was com-
pletely attenuated in the presence of IFNg-blocking antibodies.
Compared to other cytokines, IFNg substantially promoted adi-
pocyte MHCII expression and antigen-specific T cell activation.
Indeed, adipose tissue IFNg expression and circulating levels
increase with obesity and promote macrophage M1 polarization
(Pacifico et al., 2006; Rocha et al., 2008), while IFNg-deficient
mice develop less insulin resistance and steatosis than WT
mice (Wong et al., 2011), emphasizing the importance of IFNg
in adipose inflammation. Thus, we propose that leptin stimulates
ART IFNg production, increasing adipocyte MHCII to promote
TH1 differentiation, thereby resulting in an escalating cycle of
adipocyte/T cell inflammation, as depicted in Figure 6. Accord-
ingly, leptin-deficient ob/ob mice have less ART IFNg and adipo-
cyte MHCII expression and fewer adipose TH1 cells and M1CeATMs than similar-weight HFD-fed WT mice. In humans,
adipocyte CIITA expression correlates with both plasma leptin
concentration and adipocyte leptin gene expression, and SVF
IFNg expression was 3-fold elevated in obese versus lean
subjects with increased TH1 marker expression, consistent
with this mechanism.
Our study is the first to demonstrate that adipocytes can
directly activate T cells via theMHCII pathwaywhich is enhanced
in obesity. Several cell types can express MHCII and function as
APCs upon exposure to IFNg in addition to macrophages and
dendritic cells, the so-called professional APCs (Razakandrai-
nibe et al., 2012). Here, we showed that adipocytes of obese
mice activated T cells to a greater extent than those of lean
mice and, consistent with an APC role, adipocytes of obese
humans and mice exhibited marked increases in expression of
two major costimulatory genes, CD80 and CD86, expressed
exclusively on cells that stimulate T cell proliferation. Preadipo-
cytes and adipocytes have previously been reported to
acquire other phenotypic traits commonly associated with
macrophages. Charrie`re et al. showed that preadipocyte micro-
array profiles were closer to macrophages than to adipocytes
and that preadipocytes demonstrated phagocytic activity and
macrophage-specific protein expression similar to that seen in
peritoneal macrophages (Charrie`re et al., 2003). Meijer et al.
(Meijer et al., 2011) also reported that human primary preadipo-
cytes and adipocytes express cytokines, MHCII genes, and
acute phase proteins, many of which were increased by LPS
stimulation. However, these studies were performed using
primary preadipocyte cell lines before and after in vitro differen-
tiation, not ex vivo adipocytes, and these authors did not
examine the ability of these cells to activate T cells.ll Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc. 419
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ATM-dependent antigen presentation in T cell activation in
inflamed adipose tissue, but we suggest that such events occur
later in the inflammatory cascade. In contrast to adipocytes and
T cells, ATMs were unexpectedly quiescent during the first
4 weeks of HFD challenge, revealing no major changes in candi-
date proinflammatory cytokines. Moreover, MHCII expression
was not different in ATMs of obese versus lean humans or
mice. These differences between adipocyte and ATM MHCII
induction may be explained by their diverse responses to
IL-10, which attenuates both macrophage MHCII antigen
presentation and cytokine production (Turner et al., 2010). In
contrast, we observed no effect of IL-10 on IFNg-induced
MHCII expression in 3T3-L1 or primary adipocytes due to
greatly reduced IL-10 receptor expression compared to macro-
phage expression. Both adipocyte and ATM IL-10 expression
increased with time on HFD: adipocyte expression increased
2-fold within 1 week of HFD and 150-fold by 12 weeks HFD,
while ATM expression significantly increased at 12 weeks
HFD (not shown). These increases in adipose IL-10 early in
HFD-induced obesity may thus suppress APC activity of
ATMs, but not adipocytes, as shown in Figure 6. However,
during prolonged caloric excess, progressive increases in
T cell IFNg secretion and other factors, such as macrophage
lipid accumulation (McGillicuddy et al., 2009; Prieur et al.,
2011), likely promote ATM M1 polarization and macrophage
APC activity. Studies in both humans and mice demonstrate
that systemic insulin resistance can develop prior to macro-
phage changes, possibly due to increased secretion of the
T cell cytokine IFNg, which can directly impair insulin action
(McGillicuddy et al., 2009), or due to lipotoxic effects resulting
from increases in circulating free fatty acids (Lara-Castro and
Garvey, 2008; Samuel and Shulman, 2012). Thus, adipocyte
MHCII expression may contribute to CD4+ ART activation
and IFNg production early in HFD, while adipose IL-10 can
suppress ATM adaptive immune activity. Both adipocytes and
ATMs had similar MHCII expression with 3 months HFD. At
this time, newly infiltrated ATMs are reported to comprise as
much as 50% of the adipose cell population (Weisberg et al.,
2003); since ATM MHCII expression did not increase with
HFD, an enhanced number of ATMs appears necessary to
increase ATM T cell activation. Our data suggest that both
adipocytes and ATMs contribute to T cell activation late in
HFD (Figure 6).
In order to test the role of adaptive immunity in mediating
adipose inflammatory responses, we administered HFD to
MHCII-deficient H2A/ versus WT mice. Despite similar adi-
posity, HFD-fed H2A/ mice had less insulin resistance and
steatosis than WT controls, and less ART IFNg mRNA ex-
pression and reduced ATM accumulation and M1 polarization.
Even at 4 weeks HFD, prior to adipose macrophage infiltration,
thesemiceweremore insulin sensitive thanWTmice, suggesting
that deficiency of adipocyte MHCII may have contributed to
improved insulin action. Loss of APC function by both adipo-
cytes and macrophages impaired TH1 cell differentiation and
substantially reduced adipose inflammatory responses to HFD.
This finding was quite unexpected, since low CD4+ T cells and
increased CD8+ T cells, which characterize H2A/ mice, have
been reported to occur in obesity andmediate insulin resistance,420 Cell Metabolism 17, 411–422, March 5, 2013 ª2013 Elsevier Inc.and depletion of CD8+ T cells has been shown to improve insulin
sensitivity (Nishimura et al., 2009). Thus, despite a T cell profile
that would predict insulin resistance, loss of MHCII improved
metabolic responses. Of note, adipocytes of HFD-fed H2A/
mice had increased adiponectin but decreased proinflammatory
cytokine expression compared to WT mice. While adipocytes
from HFD-fed H2A/ versus WT mice were more insulin sensi-
tive, there was no difference in insulin responses in 3T3-L1
adipocytes with and without CIITA knockdown. These data
suggest that the proinflammatory milieu, rather than adipocyte
MHCII deficiency, impacts adipocyte insulin responses.
Our investigation highlights a role of adaptive immunity in
the development and progression of obesity-induced adipose
inflammation and insulin resistance. Intriguingly, other groups
have reported that CD4+ ARTs express a restricted subset of
T cell receptors (Feuerer et al., 2009; Winer et al., 2009), sug-
gesting that ARTs may recognize specific antigens in fat that
regulate adaptive immune responses to HFD, dictating T cell
maturation and lineage commitment (McDevitt, 2000). These
observations suggest that the adipocyte or other cells in the
adipose microenvironment are the source of these antigens.
Nothing is known, however, about the nature of antigens that
activate ARTs. However, several mechanisms could produce
novel antigens during obesity. For example, posttranslational
modifications, such as palmitoylation and oxidation, could
directly alter adipose-derived proteins or alter their folding and
processing to produce new antigenic variants; alternative
splicing could produce new antigenic protein isoforms; stress-
induced protease activities could alter protein processing to
produce new antigenic peptides; and ER stress-induced protein
misfolding could alter posttranslational modification and
proteolytic processing to produce new antigens. Our findings,
together with current observations in the field, provide a compel-
ling rationale to identify adipose antigens altered in obesity,
since vaccine-based strategies to induce immune tolerance
against these antigens could represent a new therapeutic
approach to attenuate inflammatory-driven complications of
caloric excess.
EXPERIMENTAL PROCEDURES
Adipocyte and SVF RT-PCR and Flow Cytometry Analyses
This study was approved by the Institutional Review Board of The Methodist
Hospital. All subjects gave written informed consent prior to participation.
Adipocytes and SVF were isolated as previously described (Halleux et al.,
1999), then fractionated with biotinylated antibodies (eBioscience, San Diego
CA) and streptavidin-Dynabeads (Invitrogen, Grand Island, NY). CD45-
depleted adipocytes were processed with RNeasy Lipid Tissue Mini kits
(QIAGEN, Valencia, CA). ATMs and ARTs were isolated from SVF with bio-
tinylated F4/80 and CD3d antibodies and RNA extracted with Trizol Reagent
(Invitrogen). RNA was reverse transcribed and amplified with Taqman mRNA
Reverse Transcription Kits and primer/probes (Applied Biosystems, Carlsbad,
CA). RNA expression was normalized to 36B4 (adipose or adipocytes) or PPIA
(ARTs and ATMs).
CD45-depleted adipocytes and SVF were hybridized with CD45-PE, CD36-
AF647, and HLA-DR-APC-eF780 antibodies (eBioscience) and analyzed on an
Imagestreamx system (Amnis, Seattle, WA). Mouse SVF fractions were hybrid-
ized with mouse CD3-Pacific Blue, CD4-FITC, and CD8-Pe-Cy7 antibodies or
F4/80-APC and CD11b-FITC antibodies and analyzed on a BD LSRFortessa
using FACSDiva Software (BD Biosciences, San Jose, CA) to detect
CD3+CD4+ and CD3+CD8+ ARTs and F4/80+CD11b+ ATMs, using appropriate
compensation controls to set gates.
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Male ob/ob (B6.Lepob/J), B6.Cg-Tg(TcraTcrb), DBA/1J, H2A/ (B6.129S2-
H2dlAb1-Ea/J), and diet-induced obese (DIO) and lean C57BL/6J mice were
from The Jackson Laboratory (Bar Harbor, ME). H2A/ and C57BL6/J
mice were randomly assigned to chow (8904, Harlan Teklad) or HFD (60%
kcal fat; D12492, Research Diets, New Brunswick, NJ) as indicated, and
analyzed for food intake (BioDAQ, Research Diets), NMR-determined body
and liver fat (Echo Medical Systems, Houston, TX), overnight-fasted blood
glucose (One-Touch, Lifescan, Milpitas, CA), and plasma insulin (Millipore,
Billerica, MA). ITTs were performed on 4 hr-fasted, nonanesthetized mice,
using tail vein blood samples obtained 0, 15, 30, 45, 60, and 90 min after
intraperitoneal insulin injection. All animal procedures were conducted in
a Specific Pathogen Free (SPF) facility at The Methodist Hospital Research
Institute in accordance with institutional animal care and use committee
guidelines.
Cell Culture
HEK293T and 3T3-L1 cells were obtained from American Type Culture Collec-
tion (ATCC, Bethesda, MD). Primary human preadipocytes were purchased
from Zen-Bio (Research Triangle Park, NC) and cultured according to the
supplier’s protocol. C57BL/6-Tg(TcraTcrb) mouse T cells were isolated with
a Pan T Cell isolation Kit (Miltenyi Biotec). Cell cultures methods are described
in the Supplemental Information.
Western Blots
Western blots were performed as described (Deng et al., 2006), using primary
MHCII, F4/80 (Abcam, Cambridge, UK), MHCI, CIITA (Santa Cruz Biotech-
nology, Santa Cruz, CA), adiponectin, and GAPDH (Chemicon, Billerica, MA)
antibodies and secondary antibodies (Cell Signaling, Danvers, MA), with
densitometry analyzed using NIH ImageJ software.
Histology and Immunohistochemistry
Mouse epididymal white adipose tissue and liver samples were fixed in
10% formalin-PBS overnight, then paraffin embedded, sectioned, and
hemotoxylin and eosin stained. Sections were hybridized with mouse F4/80
antibody (Abcam), developed using Histomouse MAX kits (Invitrogen),
and imaged using a Nikon 90i system and NIS-Elements software (Nikon,
Melville, NY).
Statistics
All data are presented as means ± SEM, and sample sizes are reported in
figure legends. Prism 5.0 software (Graphpad, San Diego, CA) was used for
all statistical analyses. Differences between groups were analyzed using
Mann-Whitney U tests, Student’s t tests, or Welch’s t tests as indicated by
data normality, variation, and statistical power.
ACCESSION NUMBERS
Raw microarray data sets have been deposited in the NCBI Gene Expression
Omnibus (GEO) database under accession number GSE44000.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at http://dx.doi.org/10.1016/j.cmet.2013.02.009.
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